The O’Neill Institute has established a Ryan White Policy Project to consider issues related to sustaining and adapting the Ryan White HIV/AIDS Program (Ryan White) within a changing health care environment. This project is supported by funding from Gilead Sciences.
Funded by the federal government at nearly $2.3 billion per year, the Ryan White program is the third largest source of financing for HIV care after Medicaid and Medicare and is the cornerstone of the Nation’s response to the domestic HIV epidemic. The purpose of this Ryan White Policy Project is to consider issues that arise as the context in which the program operates is altered both by technological advances and fundamental shifts in health care financing and service delivery with the implementation of the Affordable Care Act (ACA).
The Ryan White Policy Project is guided by an advisory group consisting of:
- Deloris Dockrey, Hyacinth AIDS Foundation
- Ernest Hopkins, San Francisco AIDS Foundation
- Connie Garner, Foley Hoag
- Emily McCloskey, NASTAD
- Bill McColl
- Carl Schmid, HIV + Hepatitis Policy Institute
- Naomi Seiler, Milken Institute School of Public Health, George Washington University
- Ace Robinson, NMAC
- Andrea Weddle, HIV Medicine Association
Better Meeting the Needs of People Living with HIV Is How to End the HIV Epidemic (April 2020)
This report highlights actions that can be taken by jurisdictions and advocates to improve the health of all people living with HIV. As community stakeholders and policymakers in the United States focus on achieving the goals of the Ending the HIV Epidemic (EHE) Initiative, many people with HIV have felt neglected and under-prioritized. To succeed at ending the HIV epidemic, differing strategies are needed to support three groups of people with HIV: (1) those who are unaware of their infection, (2) those who are in care but not virally suppressed, and (3) those who have been diagnosed but are not in care.
This Quick Take document discusses the final recommendation for pre-exposure prophylaxis (PrEP) from the United States Preventive Services Task Force (USPSTF) and why the PrEP recommendation matters. The USPSTF PrEP recommendation has the potential to increase access to PrEP for HIV prevention and means that most private health plans and all Medicaid-expansion programs must cover PrEP without cost-sharing. To support effective implementation of this recommendation, the document outlines critical actions that are needed from federal agencies, health plans, health departments and insurance regulators, and providers and communities. Implementation of the recommendation must ensure access to comprehensive PrEP services and require coverage without cost-sharing of new PrEP regimens as they become available.
One in four people living with HIV will become infected with Hepatitis C (HCV) during their lifetime. This policy brief shows how the Ryan White HIV/AIDS Program has a major role to play in helping eliminate HCV among people living with HIV. This brief identifies target populations and various barriers as well as providing strategies to address those issues. These strategic actions include comprehensive efforts to overcome barriers to treatment, better metrics for taking progress toward elimination, increased emphasis on re-screening, and stronger planning and commitment to HCV elimination in states, communities, and clinics.
Quick Take on the Ryan White HIV/AIDS Program in the United States (January 2019)
This Quick Take document discusses how the Ryan White HIV/AIDS Program is leading the way in getting people with HIV virally suppressed by ensuring stable access to HIV primary care and medication along with critical support services. The documents describes the parts of the Ryan White Program and the importance of the program for meeting the health care needs of people with HIV and addressing new challenges.
Quick Take on HIV Prevention in the United States (January 2019)
This Quick Take document provides an overview of the HIV epidemic in the United States and describes the range of tools and approaches used to prevent HIV infection, including HIV testing and linkage to care, treatment as prevention, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), and syringe and harm reduction services. The document also discusses the need for continued support for and new investment in HIV prevention.
State and Local ‘End the Epidemic’ Plans Can Drive HIV Progress (December 2018)
Released in December 2018, this report identifies key elements of a plan to ‘End the Epidemic.’ One of the most significant elements of some emerging plans is to treat HIV earlier by offering same-day or rapid start of antiretroviral therapy (ART) when individuals receive an HIV diagnosis or are re-engaged in HIV care. Other significant elements include continued focus on monitoring engagement and actively intervening to address barriers to care and an emphasis on scaling up access to pre-exposure prophylaxis (PrEP) and ensuring appropriate access to post-exposure prophylaxis. The report also provides some leading examples of jurisdictions across the county that have developed plans. The jurisdictions highlighted in the report include New York State, New York City, Washington State, the District of Columbia, Houston, and Los Angeles.
In the report, the authors outline the elements of a rapid start program and discuss common barriers to scaling up rapid start, ranging from clinician acceptance and patient readiness to insurance and AIDS Drugs Assistance Program (ADAP) eligibility. The challenge in adopting rapid start of ART is developing workable models of care that can be implemented across our diverse national health care landscape. The authors also discuss how the Ryan White HIV/AIDS Program can help overcome barriers to widespread adoption of rapid start.
The Ryan White program has led the way in the development of integrated models of care that other parts of the United States health system are seeking to replicate. It has also enabled states, territories, and local jurisdictions to mount flexible responses to their unique epidemics, while also raising the standard of care and expectations for population-level outcomes for everyone. This issue brief examines the changing role of the Ryan White program and how it supports Medicaid, Medicare, and private insurance to prevent HIV transmission and reduce health care spending.
Originally built as a standalone system, the Ryan White program has evolved to a complement to the insurance system. Nonetheless, as the health system seeks to better integrate services and design more effective and efficient care delivery models, this report offers strategies for better aligning the Ryan White program with insurance to ensure that people with HIV do not get left behind.
The Ryan White program has always looked and acted differently than other parts of the health system. This report provides recommendations for ways to streamline existing planning and monitoring activities to retain critical aspects of community engagement. It also forcefully calls for increased Ryan White program investments to build health department data management systems and capacity to better partner with Medicaid, Medicare, health plans, and HIV prevention programs to monitor engagement in care and intervene when care is interrupted.
Generations of dedicated HIV care providers and community partners have built today’s HIV care system. While more must be done to better reach underserved populations and communities, the need is great to bolster and sustain the existing HIV care workforce. This report offers recommendations for building upon recent changes to the AIDS Education and Training Center (AETC) program and other efforts to support clinical and non-clinical providers.
These reports were informed by consultations with people living with HIV, HIV medical and non-medical providers, Ryan White grantees, and federal HIV policy and program staff. The Ryan White Policy Project is supported by funding from Gilead Sciences, Inc. The report was prepared by Crowley and Garner. Crowley reports no recent personal financial interests related to the report. Garner is policy director for Foley Hoag representing Gilead Sciences.
Other project publications include:
Crowley, Jeffrey, and Jen Kates. Updating the Ryan White HIV/AIDS Program for a New Era: Key Issues and Questions for the Future.”. 2013.
Thematic Area: Infectious Diseases